NYSE:MMS - MAXIMUS Stock Price, Price Target & More

MAXIMUS trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

MAXIMUS announced a quarterly dividend on Thursday, July 12th. Shareholders of record on Wednesday, August 15th will be given a dividend of $0.045 per share on Friday, August 31st. This represents a $0.18 dividend on an annualized basis and a yield of 0.28%. The ex-dividend date is Tuesday, August 14th. View MAXIMUS's Dividend History.

MAXIMUS declared that its board has approved a stock buyback plan on Monday, June 25th 2018, which authorizes the company to repurchase $200,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 4.9% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company's leadership believes its shares are undervalued.

MAXIMUS, Inc. (NYSE:MMS) announced its earnings results on Thursday, May, 10th. The health services provider reported $0.82 earnings per share for the quarter, missing analysts' consensus estimates of $0.84 by $0.02. The health services provider had revenue of $612.79 million for the quarter, compared to the consensus estimate of $617.97 million. MAXIMUS had a net margin of 9.15% and a return on equity of 21.67%. MAXIMUS's revenue for the quarter was down 1.5% on a year-over-year basis. During the same quarter last year, the firm posted $0.80 EPS. View MAXIMUS's Earnings History.

MAXIMUS is scheduled to release their next quarterly earnings announcement on Thursday, August, 9th 2018. View Earnings Estimates for MAXIMUS.

MAXIMUS issued an update on its FY18 earnings guidance on Thursday, May, 10th. The company provided earnings per share guidance of $3.30-3.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.49. The company issued revenue guidance of $2.4-2.44 billion, compared to the consensus revenue estimate of $2.50 billion.

3 equities research analysts have issued twelve-month price targets for MAXIMUS's stock. Their forecasts range from $64.00 to $81.00. On average, they anticipate MAXIMUS's stock price to reach $69.50 in the next year. This suggests a possible upside of 6.7% from the stock's current price. View Analyst Ratings for MAXIMUS.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MAXIMUS in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to MAXIMUS include Mercadolibre (MELI), Total System Services (TSS), Worldpay (WP), CoStar Group (CSGP), Msci (MSCI), Broadridge Financial Solutions (BR), Akamai Technologies (AKAM), Alliance Data Systems (ADS), Zillow Group Inc Class A (ZG), Zillow Group Inc Class C (Z), CIELO S A/S (CIOXY), Nielsen (NLSN), GrubHub (GRUB), The Western Union (WU) and CDK Global (CDK).

Media stories about MMS stock have trended somewhat positive recently, according to Accern. Accern ranks the sentiment of press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. MAXIMUS earned a media sentiment score of 0.04 on Accern's scale. They also gave news articles about the health services provider an impact score of 47.00 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

MAXIMUS's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Riverbridge Partners LLC (1.55%), Handelsbanken Fonder AB (0.48%), Summit Creek Advisors LLC (0.25%), West Coast Financial LLC (0.14%), Contravisory Investment Management Inc. (0.11%) and Cambiar Investors LLC (0.11%). Company insiders that own MAXIMUS stock include Anne K Altman, Bruce Caswell, David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni, Richard John Nadeau and Russell A Beliveau. View Institutional Ownership Trends for MAXIMUS.

MMS stock was sold by a variety of institutional investors in the last quarter, including Handelsbanken Fonder AB, Riverbridge Partners LLC, Summit Creek Advisors LLC, Clinton Group Inc., Municipal Employees Retirement System of Michigan, Bank of Montreal Can, West Coast Financial LLC and Contravisory Investment Management Inc.. Company insiders that have sold MAXIMUS company stock in the last year include Bruce Caswell, David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni and Russell A Beliveau. View Insider Buying and Selling for MAXIMUS.

MMS stock was purchased by a variety of institutional investors in the last quarter, including Cambiar Investors LLC, Xact Kapitalforvaltning AB, Amalgamated Bank and Cim LLC. Company insiders that have bought MAXIMUS stock in the last two years include Anne K Altman and Richard John Nadeau. View Insider Buying and Selling for MAXIMUS.

Shares of MMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MMS stock can currently be purchased for approximately $65.15.

MAXIMUS has a market capitalization of $4.27 billion and generates $2.45 billion in revenue each year. The health services provider earns $209.42 million in net income (profit) each year or $3.03 on an earnings per share basis. MAXIMUS employs 20,400 workers across the globe.

MAXIMUS's mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The health services provider can be reached via phone at 703-251-8500 or via email at christinevaughng[email protected]